Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
National Cancer Institute (NCI)
PRIMARY OBJECTIVES:
Evaluate the feasibility and biodistribution of 68Ga-PSMA.
OUTLINE:
Patients are injected with 5 mCi of Ga68 PSMA intravenously (IV) and then undergo PET/CT or PET/MRI approximately 45 to 60 minutes later.
After completion of study, patients are followed up at 24 hours and 1 week.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Provides written informed consent
Known diagnosis of prostate cancer
Patient has suspected recurrence based on biochemical data (prostate specific antigen \[PSA\] \> 2 ng/mL)
Able to remain still for duration of each imaging procedure (about one hour)
You may not be if
Unable to provide informed consent
Inability to lie still for the entire imaging time
Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.)
Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance
